Clinical Trials Browser

Phase 2 × INDUSTRY × Protein Subunit Vaccines × Clear all

NCT00357461 2013-05-15

Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma

Phase 2 Withdrawn

Melanoma